0000000000466044

AUTHOR

Pier Francesco Nocini

showing 3 related works from this author

Apps for oral hygiene in children 4 to 7 years : fun and effectiveness

2019

Background Nowadays apps in preschool age are largely used in learning improvement. The aim of this work was to test effectiveness of apps in improving oral hygiene in children patients aged from 4 to 7 years and evaluating correlation between parents educational attainment and children oral hygiene. Material and methods 100 patients aged from 4 to 7 years were randomly assigned by an external office in the study group (SG: 32 females, 18 males) and in the control group (CG: 28 females and 22 males). Plaque index (PI) and carious lesions localisation were detected. At baseline all patients and one of the parents were instructed at chair-side about the proper oral hygiene techniques. SG pati…

medicine.medical_specialtyPlaque indexEvery Three MonthsEducational attainmentOral hygieneChildren oral hygiene03 medical and health sciences0302 clinical medicineMedicine030212 general & internal medicineGeneral DentistryPreschool childMotivationbusiness.industryResearchApps030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Educational attainmentCommunity and Preventive DentistryTest (assessment)stomatognathic diseasesFamily medicineUNESCO::CIENCIAS MÉDICASOral hygiene complianceApps Children oral hygiene Educational attainment Motivation Oral hygiene compliancebusiness
researchProduct

Peripheral ameloblastoma of the upper gingiva: Report of a case and literature review

2014

According to the 2005 histological classification of odontogenic neoplasms by the World Health Organization, ameloblastoma is a benign, locally invasive epithelial odontogenic tumor of putative enamel organ origin. There are four distinct subgroups in which this neoplasm can be gathered: the solid/multicystic type, the unicystic type, the desmoplastic and the peripheral type. Peripheral ameloblastoma is believed to be the rarest subgroup, making up for 2 to 10% of all ameloblastomas. From its first description by Kuru in 1911 to date, less than 200 cases of PA have been described in literature. PAs commonly affect the mandible, in the maxilla the most common location is the soft palatal tis…

Pathologymedicine.medical_specialtyCase ReportOdontologíaAmeloblastoma; Oral Disease; Oral surgeryLesionAmeloblastomaOral surgeryPeripheral ameloblastomamedicineAmeloblastomaGeneral DentistryPathologicalOral DiseaseOral Medicine and Pathologybusiness.industryMandibleEnamel organOdontogenic tumormedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludstomatognathic diseasesMaxillaUNESCO::CIENCIAS MÉDICASmedicine.symptombusiness
researchProduct

Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus.

2008

Background Oral lichen planus (OLP) is considered to be an autoimmune disease of unknown aetiology that affects the mucosae, especially the oral cavity. Objective We compared tacrolimus 0.1% ointment and clobetasol 0.05% ointment for the treatment of OLP. Patients and methods A total of 32 patients (20 females and 12 males; all white, Italian origin, mean age of 43.6+/-18.4 years; 16 patients per treatment group) were treated with tacrolimus or clobetasol ointment for 4 weeks in a randomized, double-blind, clinical trial. Pain severity, burning sensation, and mucosal lesion extension were assessed using a four-point scale. Results At the end of the treatment period, symptom scores were sign…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina Internamedicine.drug_classAnti-Inflammatory Agentstacrolimus ointment; clobetasol ointment; oral lichen planuslaw.inventionOintment Basesoral lichen planusRandomized controlled triallawOral administrationFacial PainmedicineHumanstacrolimus ointmentSalivatacrolimusbusiness.industryclobetasol ointmentclobetasol; tacrolimus; oral lichen planusmedicine.diseaseDermatologyTacrolimusCalcineurinstomatognathic diseasesclobetasolOintment BasesPeriodonticsCorticosteroidOral lichen planusFemaleClobetasol propionatebusinessEpidemiologic MethodsImmunosuppressive Agentsmedicine.drugLichen Planus Oral
researchProduct